| | | | | | | | | | | | | | | | | | | | | |
Ownership Document |
Schema Version: X0306 |
Document Type: 4 |
Period of Report: 2/11/20 |
Not Subject to Section 16: 0 |
Issuer: |
| Issuer CIK: 1427925 |
| Issuer Name: ACELRX PHARMACEUTICALS INC |
| Issuer Trading Symbol: ACRX |
Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1310803 |
| | Owner Name: Dasu Badri N |
| Reporting Owner Address: |
| | Owner Street 1: C/O ACELRX PHARMACEUTICALS, INC. |
| | Owner Street 2: 351 GALVESTON DRIVE |
| | Owner City: REDWOOD CITY |
| | Owner State: CA |
| | Owner ZIP Code: 94063 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: Chief Engineering Officer |
Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 2/11/20 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: F |
| | | Equity Swap Involved? No |
| | Transaction Timeliness: |
| | | Value: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 5,613 |
| Footnote ID: F1 |
| | | Transaction Price Per Share: |
| Value: 1.71 |
| | | Transaction Acquired-Disposed Code: |
| Value: D |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 157,654 |
| Footnote ID: F2 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
Footnotes: |
| Footnote - F1: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. |
| Footnote - F2: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |
Remarks: |
Owner Signature: |
| Signature Name: /s/ Martha Adler, Attorney-In-Fact |
| Signature Date: 2/13/20 |